Medical Coatings Market Report 2026

The medical coatings market size has grown exponentially in recent years. It will grow from $12.51 billion in 2025 to $15.3 billion in 2026 at a compound annual growth rate (CAGR) of 22.3%. The growth in the historic period can be attributed to rising surgical procedure volumes, growth of medical device manufacturing, increasing prevalence of hospital-acquired infections, expansion of implantable device usage, advancements in coating material science.

The medical coatings market size is expected to see exponential growth in the next few years. It will grow to $33.73 billion in 2030 at a compound annual growth rate (CAGR) of 21.8%. The growth in the forecast period can be attributed to increasing demand for next-generation medical devices, rising focus on patient safety and outcomes, expansion of minimally invasive procedures, growing adoption of biodegradable coatings, increasing regulatory emphasis on device performance. Major trends in the forecast period include growing adoption of antimicrobial coatings for infection control, rising demand for hydrophilic coatings in minimally invasive devices, increasing use of drug-eluting coatings, expansion of biocompatible polymer coatings, enhanced focus on sterilization-compatible coatings.

Growing incidences of obesity are expected to drive the growth of the medical coatings market. Obesity, defined as having a body mass index of 30 or more, increases the need for durable and corrosion-resistant medical devices used in obesity-related surgeries, ensuring their long-term safety and effectiveness. For instance, in May 2025, according to the Office for Health Improvement & Disparities, a UK-based government department, an estimated 64.5% of adults aged 18 and over in England were overweight or living with obesity in 2023-2024, up from 64% in 2022-2023, reflecting a continuing upward trend. Therefore, growing incidences of obesity are driving the growth of the medical coatings market.

Major companies in the medical coatings market are focusing on advanced coating solutions to gain a competitive edge. Diofan Ultra736 is a polyvinylidene chloride (PVDC) coating designed for more sustainable pharmaceutical blister films. In October 2023, Solvay, a Belgium-based chemical company, launched Diofan Ultra736, featuring an ultra-high-barrier PVDC coating that provides exceptional water vapor protection. This allows the use of thinner thermoforming films without compromising product integrity, enhancing sustainability by reducing material usage while safeguarding pharmaceuticals from moisture, oxygen, and other external factors.

In July 2023, Biocoat Inc., a U.S.-based hydrophilic biomaterial coating company, acquired Chempilots, a Denmark-based manufacturer of medical coatings, for an undisclosed amount. This strategic acquisition aligns with Biocoat's mission to enable medical innovation by expanding its biomaterial platform and providing a comprehensive portfolio of customized biomaterial solutions.

Major companies operating in the medical coatings market are Allvivo Vascular Inc., AST Products Inc., Biocoat Incorporated, Coatings2Go LLC, Covalon Technologies Ltd., Harland Medical Systems Inc., Hemoteq AG, Medicoat AG, Merit Medical Systems Inc., AeonClad Coatings LLC, Applied Medical Coatings LLC, Applied Membrane Technology Inc., Calico Coatings, Carmeda AB, Freudenberg Medical LLC, Hydromer Inc., Kisco Ltd., Materion Corp., DSM Biomedical B.V., Surmodics Medical Ltd., Precision Coating Company, BioInteractions Ltd., Sono-Tek Corporation, Specialty Coating Systems Inc., Biomerics LLC, EuroMed Inc., Innovative Surface Technologies, N2 Biomedical, Orchid Orthopedic Solutions, Plasma Coatings.

North America was the largest region in the medical coatings market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the medical coatings market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical coatings market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical coatings market consists of sales of fluoropolymers, parylene and silicone. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.